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ABSTRACT
Introduction: A significant number of adolescents
suffer extensive and enduring difficulties such as social
anxiety, body image dissatisfaction, low self-esteem
and bullying as a result of conditions or injuries that
affect their appearance (eg, craniofacial and skin
conditions, treatment side effects and scarring).
Evidence-based psychosocial interventions to meet
their specific needs are currently lacking. YP Face IT,
developed by the UK’s Centre for Appearance Research
in collaboration with clinical experts and young people,
is an innovative online psychosocial intervention
designed to offer this group immediate support, advice
and coping strategies. It has been endorsed by young
people, their parents/carers, GPs, clinical psychologists
and health professionals working with those affected
by appearance-related conditions.
Methods and analysis: Young people aged 12–17
with an appearance-altering condition/injury that self-
identify as experiencing appearance-related distress,
teasing or bullying will be invited to participate via GP
practices and UK charities. Consenting participants will
be randomised to the intervention (YP Face IT) or the
treatment as usual (TAU) control group. Outcome
measures will be completed by young people and their
parents/carers at baseline, 13, 26 and 52 weeks.
Primary outcome measures will be the Body Esteem
Scale and the Social Anxiety Scale for Adolescents.
Participants will complete other health-related outcome
measures and resource use questionnaires for health
economic analysis. We will assess recruitment rates,
acceptability of the YP Face IT programme, adherence
and retention to treatment, questionnaire completion
rates, variation of TAU in Primary Care and the
feasibility of GP practice staff supervising young
people’s use of YP Face IT.
Ethics and dissemination: This feasibility trial
protocol (V.1, 3 March 2014), received a favourable
ethical opinion from the NRES Committee South West-
Frenchay (reference number 14/SW/0058). Findings
will be disseminated through academic peer-reviewed
publications, conferences and to participating GP
practices and charities supporting those with
conditions affecting appearance.
Trial registration number: ISRCTN40650639;
Pre-results.
INTRODUCTION
Looking ‘different’ due to disease, treat-
ments, injury or congenital conditions (eg,
skin conditions, scarring, cleft lip and palate)
can have a significant psychosocial impact
during adolescence.1–4 While it is important
to highlight that many people living with a
visible difference (‘disfigurement’) adjust
well to their condition and report increased
well-being, self-acceptance and stronger
Strengths and limitations of this study
▪ This is the first feasibility study to evaluate an
online psychosocial intervention for young
people living with a visible difference in an NHS
Primary Care setting.
▪ Public and patient involvement has informed the
intervention and study design.
▪ Feasibility data will be supplemented by qualita-
tive data from young people, their parents/carers
and GP practice staff.
▪ Participant outcomes, including 12-month
follow-up, are self-reported.
▪ Participants are not blinded to allocation and this
could lead to reporting bias.
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social relationships,5 around a third of young people
living with a visible difference suffer extensive and
enduring difficulties, including bullying, low self-esteem,
body image dissatisfaction, social anxiety and avoidance,
poor quality of life and academic performance.6–9
Anxiety and avoidance interfere with social and emo-
tional development and, if not addressed, can become
chronic and disabling, leading to anxiety disorders
which are an economic burden for society.10
Research consistently shows that location, size and
cause of a visible difference do not accurately predict
levels of appearance-related distress.11 12 Rather, well-
being is often determined by intervening sociocognitive
factors, including social confidence, perceptions of
social acceptance and fear of negative evaluation.13
These factors are amenable to change via psychosocial
interventions that encourage the development of self-
management skills and offer an adjunct or alternative to
medical and surgical solutions.14
Psychosocial interventions for appearance-related distress
Evidence-based psychosocial interventions to meet the
specific needs of young people with appearance-related
distress associated with a visible difference are currently
lacking.15 16 There is some evidence, albeit limited, that
interventions based on cognitive–behaviour therapy (CBT)
and social interaction skills training (SIST) may be as
effective for young people15 as evidence suggests they
are for adults.14 17 Face IT is a successful online interven-
tion for adults that uses SIST and CBT for appearance-
related distress. Its therapeutic content was informed by
Kent’s18 Model of Psychosocial Distress and Intervention
for Individuals with Visible Differences which purports
that an unusual appearance, perceived as unattractive by
the individual, can increase negative appearance-related
cognitions and fear of rejection. When combined with
experiences of social stigma, these experiences can
heighten social anxiety, resulting in individuals appear-
ing distracted or anxious, which inhibits effective social
functioning.19 In a randomised controlled trial (RCT),
Face IT reduced anxiety-related concerns and was com-
parable to a face-to-face CBT intervention. These
improvements increased at 6-month follow-up.20
Developing young person’s Face IT (YP Face IT)
The project to develop and evaluate a young persons’
version of Face IT is following the Medical Research
Council framework for the development of complex
interventions.21 To date, this has involved a series of
acceptability studies with young people with a range of
appearance-altering conditions (including those with
skin/craniofacial conditions and scarring), their parents,
clinical experts (psychologists, consultants and specialist
nurses working with those affected by appearance-
altering conditions) and General Practitioners (GPs).16
In these studies, participants rejected adult Face IT as a
suitable intervention and collaborated with researchers
to develop a youth version (YP Face IT), with similar
therapeutic content but revamped to meet the specific
developmental and cultural needs of adolescents. YP
Face IT (http://www.ypfaceit.co.uk) has attractive multi-
media presentations and is appropriate for 12–17 years
with a reading age of 12 years and readability levels of
90–100%.22
Young people have endorsed YP Face IT over face-
to-face therapy because it can be accessed in private, at
their convenience and because they would feel less
embarrassed/inhibited taking part.16 Psychologists have
welcomed its potential to address a current gap in care
provision and to overcome barriers that prevent young
people and parents using their services, including
needing time off school/work, travelling, perceived
stigma of therapy23 and social anxiety/avoidance: a
defining characteristic of this group.24 GPs, parents and
young people have also requested that YP Face IT be
made widely available with minimal limitations on who
can access it, as GPs report they struggle to iden-
tify appropriate evidence-based appearance-specific psy-
chological interventions.25 In addition, those with
appearance-related distress rarely meet criteria for refer-
ral to Child and Adolescent Mental Health Services
(CAMHS) and many receiving secondary care for their
condition have no, or limited, access to a psychologist.16
Providing easily accessible interventions is in line with
current policy26 and calls for innovations to improve
access to primary care services.27
YP Face IT is an innovative, widely acceptable interven-
tion offering immediate support, advice and strategies to
young people affected by appearance-related distress,
with potential benefits in terms of improved quality of
life for a large and diverse user group. Advantages
centre around addressing an unmet need and targeting
low body image and social anxiety; which have multiple
short-term and long-term impacts on public health and
NHS resource use.4 28–30
METHODS AND ANALYSIS
Participants and recruitment
The target population is 12–17 years living with a visi-
ble difference who self-identify as experiencing
appearance-related distress, teasing or bullying. Charities
supporting those with a visible difference (eg, http://
www.changingfaces.org.uk) will be approached to ask
them to advertise the study via their websites and newslet-
ters to young people and parents. The main avenue for
recruitment will be through primary care general prac-
tices that do not specialise in appearance-related issues;
sites in Bristol and surrounding areas in the South West
of the UK will be invited to take part. To increase repre-
sentativeness of participants from a range of socio-
economic backgrounds, we will aim to include practices
with a range of index of multiple deprivation scores.
Based on advice from our YP Face IT advisory group
(including GPs, parents/carers and young people),
patients from GP practices will be made aware of the
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study in three ways; through targeted letters of invitation
and, to enable introduction of the study to those whose
appearance-altering condition is not recorded in their
medical notes, via posters/leaflets displayed in the
surgery and during consultations. How participants
learnt about the study will be recorded to inform
recruitment for a future RCT.
With the support of the West of England NIHR
Clinical Research Network, a comprehensive list of con-
ditions/injuries known to impact appearance were used
to create a specific list of READ codes (medical diagno-
sis coding system used by practices). GP practices
recruited to take part in the study will use these codes to
identify eligible patients. GPs will review this list and at
their discretion remove those deemed not suitable for
invitation (eg, those whose condition has resolved).
Young people will be posted an information pack,
including a GP invitation letter and information sheet.
For those under 16 years, letters will be addressed to
their parents/carers who will be asked to discuss partici-
pation with their child. A reminder will be sent 4 weeks
later to non-respondents, this will include a response
form for indicating why they decided not to take part
and self-addressed envelope.
Doctors and nurses from GP practices will be asked to
recruit young people who meet the inclusion criteria
during consultations. We anticipate that the GP practices
we recruit will not have extensive experience of raising
the topic of appearance with young people; therefore,
GPs and nurses will receive training from the YP Face IT
team on how to approach and sensitively introduce the
study. Staff will provide interested young people with
information sheets and leaflets. These will include details
for contacting the research team. Posters, designed with
input from the advisory group, will be displayed in par-
ticipating practices inviting young people to contact their
GP if the study is of relevance.
Inclusion criteria
Young people aged 12–17 years with any appearance-
altering condition, injury or treatment side effect, who
self-identify as experiencing appearance-related distress,
teasing or bullying and their parent/carer will be eli-
gible. The cause, location and severity of the visible dif-
ference will not be objectively assessed, as research
consistently finds physical characteristics do not relate to
distress levels.11 Participants under 16 years will require a
parent/carer to join the study, those aged 16 or above
will be encouraged to inform and involve their parent/
carer, but this is not mandatory. Participants need to be
fluent in English (audio clips are built in to the pro-
gramme for those who struggle reading text) with
normal/corrected-to-normal vision and access to a
private computer or tablet.
Exclusion criteria
We will exclude participants with a learning disability
that compromises their ability to provide informed
consent. Those currently receiving a psychological inter-
vention, diagnosed with clinical depression, psychosis,
eating disorder or posttraumatic stress disorder (PTSD)
and those within 12 months of a traumatic injury will be
excluded. PTSD is a risk for those disfigured through
trauma.31 GP practices will be asked to screen for study
eligibility before inviting young people to participate.
Confirmation of this eligibility will rely on parent and
young people’s self-report when the researcher speaks to
them over the telephone before informed consent is
obtained. An example of the consent form can be found
in online supplementary appendix 1.
Study design
The study will be a 2-year feasibility RCT starting July
2014. Remote randomisation will be provided by the
Bristol Randomised Trials Collaborative based at the
University of Bristol, with eligible participants rando-
mised to ‘Treatment as Usual’ (TAU-control group) or
YP Face IT in addition to TAU (intervention group).
Block randomisation will help ensure equal numbers in
each practice are allocated to each condition. A prag-
matic parallel-groups RCT, using current practice as the
control arm, was acceptable to our advisory group and is
the most methodologically robust design to measure self-
report psychological outcomes. Randomisation will
ensure that in the definitive trial, effects due to condi-
tion progression will be equally distributed across
groups. Participants who meet our inclusion criteria and
their parent/carer will be consented by the research
team and asked to provide demographic information. At
baseline, young people and their parent/carer will be
asked to complete their outcome measures, consented
participants will then be randomised to the TAU-control
or intervention group. Owing to the nature of the inter-
vention, neither the participants, GP practice staff nor
researchers can be blinded to allocation. Participants
will be informed that this is a feasibility study and that
YP Face IT has not yet been proven effective. Online
supplementary appendix 2 details the feasibility trial
process diagrammatically.
Treatment as usual
Participants in the control arm will continue with
TAU and complete their outcome measures at base-
line and 13, 26 and 52-week follow-up. Feedback from
GP advisors confirms TAU varies widely, including
limited advice, referral to Mood Gym32 (an online
intervention ie, not appearance-specific), inpractice
counsellors or onward referral to CAMHS. This is a
pragmatic trial and no participants will be denied
access to alternative treatments and services offered
by the NHS or other organisations. Details of the type
and frequency of TAU received will be collected via
health economic data collection tools, note reviews
and interviews.
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Intervention
YP Face IT will be provided in addition to TAU for those
randomised to the intervention group. Participants will
also complete outcome measures at baseline and 13, 26
and 52-week follow-up. The intervention consists of 7
weekly sessions each lasting around 30–40 min, and a
booster session 6 weeks later to maintain therapeutic
effect. Sessions provide advice and support in written,
audio and video formats and include interactive and
homework activities that teach and encourage users to
practise strategies such as managing staring or bullying.
Social skills, anxiety-management and CBT techniques
are taught to overcome social anxiety and target negative
appearance-related thoughts and behaviours that reduce
self-esteem. Video inserts feature adolescent actors with
a visible difference, who play different roles in scenarios
scripted and created for the programme. Participants
can hear testimonies from celebrity role models with
appearance-altering conditions, learn from others who
have adjusted positively to the challenges of living with a
visible difference and can reflect on their own experi-
ences via an online diary. To facilitate adherence to the
intervention, participants identify a suitable day and
time to complete their next session using the YP Face IT
calendar. They (and a parent/carer if they choose)
receive automated emails and/or texts 24 and 1 hour
before to remind them to complete the session. The
content of YP Face IT is organised as follows:
▸ Session 1: Common problems
▸ Session 2: Improve your social skills
▸ Session 3: Don’t be SCARED, REACH OUT
▸ Session 4: ‘Think, Feel, Do’
▸ Session 5: SMART goals
▸ Session 6: Beating anxiety
▸ Session 7: Looking at your progress
▸ Session 8: Booster quiz
Young people randomised into the intervention group
will receive an email with the YP Face IT website link
and a secure username and password to access the inter-
vention. Participants complete the intervention at home
or in a location of their choice using a computer/tablet.
Participants’ use of the intervention will be monitored
by the research team who have privileged access to data
stored on the website. An administration area within YP
Face IT records the participant’s diary entries and quali-
tative responses to reflective activities and homework
tasks and records their engagement with the website
(pages viewed and time spent on each activity). In add-
ition, to evaluate the feasibility of primary care staff
supervising young people completing YP Face IT, 5–8
practices will receive training to enable them to access
data and monitor their own patients.
Trial design characteristics
We assessed the characteristics of the feasibility study
using the pragmatic-explanatory continuum indicator
summary (PRECIS-2)33 in relation to eligibility, recruit-
ment, study settings, flexibility of intervention delivery
and adherence, follow-up, primary outcome and
primary analysis. PRECIS is an accepted tool for asses-
sing trial design on a continuum of effectiveness versus
efficacy. Pragmatic trials aim to evaluate the effectiveness
of an intervention in a real-life setting and with a study
population that is similar as possible to those that will
use it. Exploratory trials aim to explore whether the
intervention can work under ideal conditions, whereas a
pragmatic approach aims to explore whether the inter-
vention works under usual conditions.33 34 Figure 1
shows the current feasibility study design based on the
nine criteria. Specifically, eligibility, delivery and primary
analysis follow more pragmatic approaches, while recruit-
ment, setting, organisation, adherence follow-up and
primary outcome fall along the pragmatic-explanatory
continuum. We will consider amendments to the domains
within the PRECIS tool when designing a full RCT in
order, to improve the external validity of any definitive
results.
Feasibility outcome
The study aims to establish whether it is acceptable and
feasible to conduct an RCT to evaluate YP Face IT as an
adjunct to TAU in a primary care setting, with specific
consideration of:
▸ Adherence and retention to treatment and outcome
measures;
▸ Participants’ experiences of using the intervention or
being randomised to receive TAU only;
▸ The variation of TAU provided by GP practices;
▸ Participants’ views on data collection processes and
responses to self-report measures (including comple-
tion rates and time to complete) to determine the
suitability of the outcome measures;
▸ Choice of, and ability to collect, data for a health eco-
nomic evaluation;
▸ The feasibility of GP practice staff supervising young
people’s use of YP Face IT;
▸ The suitability of processes for ensuring participants
are supported as they work through the intervention
and receive onward referral, if necessary;
▸ Numbers of eligible participants recruited via GP
practices.
Clinical outcome
We will assess the impact of YP Face IT on various psy-
chosocial outcome measures, completed by participants
online using the Qualtrics data capture tool (http://
www.qualtrics.com), which have been chosen based on
their scientific merit and use in appearance-related
research.
Primary outcome measures
Body Esteem Scale
This self-report scale for adolescents and adults mea-
sures body esteem (BE)—a self-evaluation of one’s body
or appearance.35 The BE-appearance subscale (10
items) was selected for the current study as it refers to
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general feelings about appearance. Feelings are rated on
a 5-point scale from 0 (never) to 4 (always).
The BE Scale was chosen over other measures such as
the Multidimensional Body-Self Relations
Questionnaire36 as it is validated with children and ado-
lescents. Additionally, young people from our advisory
group preferred it as it was quick and easy to complete.
Social Anxiety Scale for Adolescents scale
This self-report scale for adolescents assesses feelings of
social anxiety in the context of peer relations.37 It con-
tains 22 items and asks young people to describe how
they feel in relation to each statement. Feelings are
rated on a 5-point scale ranging from 1 (not at all) to 5
(all the time). The parent version has the same items
but asks the parent to rate their child’s feelings and
behaviour. This measure was chosen as social anxiety
and avoidance is a major outcome of poor adjustment to
a visible difference and evidence from our systematic
review15 recommends its use.
Secondary outcome measures
Social skills improvement system
This self-report scale assists professionals in screening
and classifying young people suspected of having signifi-
cant social skills deficits (eg, with communication and
cooperation); scales are completed by the child and the
parent.38 Young people indicate how true a statement is
about each social skill and problem behaviour using a
4-point scale of 0 (not true) to 3 (a lot true). Parents
indicate the frequency in which the young person exhi-
bits each social skill. This is rated on a 4-point scale
from 0 (never) to 3 (almost always). This measure was
selected as there are very few validated measures avail-
able that evaluate the social skills that YP Face IT aims to
improve. Additionally, an alternative to the SSIS that is
commonly used39 was rejected by our advisors as having
inappropriate items for those with visible differences
(eg, those relating to ‘normal’ facial expressions).
Self-perception profile
This self-report measure captures how one defines the
self and contains nine subscales, each with five items.40
Young people are asked to choose which of two state-
ments they are most like, and then decide whether the
selected statement is ‘Really True for Me’ or ‘Sort of
True for Me’. Only the Romantic Appeal (YP Face IT
addresses common romantic concerns) and Global
Self-Worth subscales have been selected for the current
study. The measure was chosen because romantic issues
and concerns are highly relevant to this group41 and are
addressed within YP Face IT.
Perceived Stigmatisation Questionnaire6 This self-report
measure assesses the extent to which young people
experience stigmatising social behaviour. It has three
subscales: the absence of friendly behaviour, confused
and staring behaviour and hostile behaviour by others.
Young people are asked to rate how often people act in
a certain way towards them on a 5-point scale ranging
from 1 (never) to 5 (always). This measure was selected
to establish whether the strategies included within YP
Face IT will impact on young people’s perceived stigma-
tisation, as young people regard this outcome as highly
salient to their quality of life.42
EQ-5D-5L
This self-report measure assesses health status in order
to provide a simple, generic measure of health for clin-
ical and economic evaluation of healthcare.43 It was
selected as it is suitable for those aged 12 years and over.
The EQ-5D-5L comprises five dimensions: mobility, self-
care, usual activities, pain/discomfort and anxiety/
Figure 1 PRECIS-2.
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depression. It includes a visual analogue scale which asks
respondents to self-rate their health from 0 (the worst
health you can imagine) to 100 (the best health you can
imagine).
Qualitative outcomes
After completing the intervention (or at 13 weeks for
the control group), a purposeful sample of 15–20 young
people and parents/carers will be invited to participate
in semistructured interviews lasting 20–30 min. We will
offer the option of telephone interviews and continue to
interview until data saturation has been reached. Using
interview guides (see online supplementary appendix 3)
developed with input from the advisory group, we will
explore views on the acceptability and feasibility of
recruitment processes, randomisation, retention and
outcome measures. Intervention group interviews will
also investigate experiences of completing YP Face IT.
After 12 months, interviews will be conducted with a
range of 10–12 young people (from the intervention
and control group) to explore their experiences of the
full study, including all follow-ups. Interviews will be
digitally recorded and transcribed verbatim, before tem-
plate data analysis44 is conducted by the researcher who
will keep a reflective journal throughout.
Practice staff supervising young people completing the
intervention will be invited for interview when all of
their patients randomised to YP Face IT have finished
the intervention. This will explore the feasibility of GP
practice staff supervising young people completing the
programme, and their views on recruitment processes,
barriers and facilitators to recruitment and retention.
Health economic data collection and analysis
We will prepare the data collection methods needed to
undertake an economic evaluation in a definitive trial,
from a patient and parent/carer perspective. In the
future, we expect YP Face IT to follow a commercialisa-
tion pattern such as that used by ‘Beating the Blues’, an
online intervention for depression45 which is currently
offered in primary care for a yearly licence fee per prac-
tice. We will collect the resource use required by the GP
practice to deliver and support the running of YP Face
IT in trial records, including staff grades and time neces-
sary, and use hourly wages, on-costs and indirect costs to
value staff’s time. We will liaise with companies providing
similar computerised healthcare to estimate licence
fee cost. Other resource use will be collected from base-
line until 12-month follow-up by reviewing GP records
and parent-completed resource use questionnaires.
Participant questionnaires will be completed online at
13, 26 and 52-week follow-up by the YP or parent, and
will include resource use required to deliver healthcare
in the community, use of social services, private expenses
(eg, make up, wigs) and productivity losses, including
parent/carer time off work and children’s days off
school. We will further cross check patient-reported com-
munity healthcare resource use by asking participating
GP practices to review young people’s GP records at
52 weeks. Resources will be valued using unit costs for
health and social care,46 47 the British National
Formulary,48 ONS average weekly earnings,49 the AA
(travel costs) or local sources (eg, computerised health-
care companies). We will employ sensitivity analysis to
account for uncertainty in our costing assumptions (eg,
cost of delivering the intervention). We will examine dis-
tributions and trends in costs and quality-adjusted life
years to determine potential cost drivers and reduce
sources of missing data in the future trial. If results from
this study indicate a longer time frame is required to
capture all health benefits and costs from the interven-
tion, then we will plan for a decision analytical model in
the future economic evaluation.
Proposed sample size and data analysis
Quantitative data will be collected throughout the feasi-
bility study to better understand the number of eligible
young people, estimate willingness of young people and
parents/carers to participate and the proportion finding
randomisation acceptable. No formal power calculations
are undertaken in feasibility studies; instead, a suitable
number of participants are recruited to gain knowledge
about factors such as attrition and recruitment in rela-
tion to feasibility outcomes.50 Using 10 sites, it is esti-
mated a minimum of 100 young people would be
eligible, with more than 60 providing consent for partici-
pation. These projected feasibility sample sizes allow
consent percentage to be estimated with 95% confi-
dence to within ±11%. Under a worst-case scenario, the
projected feasibility sample sizes would allow acceptabil-
ity rates and completion rates to be estimated with error
margins of ±13%. Low participation in the TAU group
would be a concern and a sample of 30 allocated to this
group would have in excess of 80% power for detecting
a 50% or lower participation rate against an anticipated
rate 75% or higher and would therefore confidently dis-
criminate between low and good participation rates.
Percentage missing values will be determined at each
data collection stage and used to inform acceptability of
the chosen outcome measures. Estimated participation
rate per practice patient population and questionnaire
completion percentages will be used to project the
number of practices and sampling duration necessary for
the sample size in an RCT. Simulation using participation
rate information and response completion profiles of par-
ticipants will inform these calculations. A feasibility
sample size of 60 will ensure variation in individual ques-
tionnaire completion will be factored into the projected
sample size determination. Findings will determine sensi-
tivity to change of the proposed outcome measures and
establish confidence in intervention effect. For a medium
effect (Cohen’s d=0.5), sample mean values for outcome
measures based on 30 per group should align in the
hypothesised direction of patient benefit ∼98% of the
time. Sample sizes will permit SD of outcomes to be esti-
mated within 25% of the true SD.
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Trial status
Recruitment of participants is completed. The first par-
ticipant was enrolled in September 2014. The last par-
ticipant will complete follow-up in September 2016.
ETHICS AND DISSEMINATION
Ethical and safety considerations
Obtaining informed consent from participants
Every young person will be provided with a participant
information sheet when invited to take part in the study,
or after making contact with the research team.
Parents/carers will receive their own information sheet.
These will provide information about the possible bene-
fits and risks of taking part and participants will be given
the opportunity to discuss the study with their GP or
member of the research team before providing consent.
When contacted by potential participants, the researcher
will discuss participation and ensure eligibility. Those
under 16 years will require parental consent. Those
16 years and over will be encouraged to seek parent/
carer involvement and, if positive, a parent/carer will
also be consented. Consent will be taken from young
people and their parent/carer (if applicable) either in
written form or verbally through a recorded telephone
conversation with a member of the research team. Only
after consent has been provided and the baseline mea-
sures completed will randomisation occur. Each partici-
pant will be given a £10 gift voucher (sent via email) as
a token of gratitude for their time and participation fol-
lowing completion of 13, 26 and 52-week follow-up ques-
tionnaires. The explicit wishes of the participants will be
respected, including the right to withdraw from the
study at any time without giving a reason. During
informed consent, participants will be advised that the
data they provide up until the point of withdrawal will
be used. Contact details for further information will be
provided.
Safeguarding
YP Face IT is a self-help programme designed for use
without additional input from health professionals.
However, our research and the British Psychological
Society’s recommendations for online interventions51
have informed a safeguarding/supervision plan. Online
data provided by young people will be reviewed online
and ‘signed off’ each week by a researcher and a nurse/
GP from their practice (if trained), who will check diary
entries and qualitative data for safeguarding concerns
(eg, signs of abuse or self-harm). Any concerns will be
recorded as an adverse event, reported to the chief
investigator and discussed with our clinical psychologist
advisor who, if necessary, will make contact with the
young person or parent/carer. Any further concerns or
actions will be reported to the participant’s GP who will
respond following their usual protocols. This follows
advice from our experts and replicates the established
model of supervision by trained ‘administrators’ in
primary care used by the ‘Beating the Blues’ online
intervention. We will record compliance and compare
whether researchers and practice staff identify the same
entries as cause for concern. Email enquiries from parti-
cipants will be sent to a single address managed by
researchers (Monday–Friday, 9:00–17:00) who will
record details and time taken to respond. Our accept-
ability studies found young people rarely use this service
but consider it important to know professionals are
available.
Young people specifically requested an online forum
within YP Face IT; these are known to offer beneficial
social support.52 53 Users must agree to forum ‘rules’
imitating those used by ChildLine and health-related
website forums. The forum will be moderated Monday–
Friday. If young people ‘report abuse’, posts are auto-
matically removed and the research team are notified
immediately via email. No such problems arose in our
acceptability studies. We will record time spent moderat-
ing the forum, participants’ usage and discuss experi-
ences of using this facility during interviews. This will
inform future intervention costing and whether the
forum is retained for any future RCT.
Data protection/confidentiality
All data will be stored in accordance with the Data
Protection Act, 1998. Participant identifiable informa-
tion will be locked in a filing cabinet within a secure
office accessible only to the researchers. All participants
will be allocated an ID to anonymise their data and iden-
tifiable data will be stored separately to anonymised
data. Data entered by participants (eg, diary entries) are
saved (protected by VeriSign security) on the website
database, which is only accessible to the researchers, and
the web designers who comply with University and NHS
data protection policies and who will provide IT support
for this and any subsequent studies. Practice staff named
as supervisors for YP Face IT will only have access to the
data of those participants who belong to their practice.
Research governance, safety and the conduct of the study
The study procedure and intervention were assessed to
be of low risk for patient safety and it was decided an
independent data monitoring committee was not
required and interim analyses will not be conducted. A
trial steering group will be set up with an independent
chair and at least two other independent members and
will meet 6 monthly. It will provide overall supervision of
the study on behalf of the funders and the sponsor and
will concentrate on the study progress, protocol adher-
ence, patient/participant safety, consideration of new
information and ensure that the study is conducted to
the standards set out in Guidelines for Good Clinical
Practice.54 The senior management team (principle
investigator, researchers, clinical psychologist, health
economist and statistician) will meet monthly to discuss
protocol adherence, any protocol amendments for
ethical approval by NRES Committee South West and
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study progress. Only members of the study management
group will have access to the final data set.
Dissemination of research findings
The outcome of this feasibility study will inform our
plans for a definitive trial. In order to maximise the
success and take-up of such a study, and the use of the
intervention if it is shown to be beneficial, we will ensure
that this feasibility study is appropriately disseminated.
Our advisory group will provide advice on the dissemin-
ation of the findings to patients, parents/carers and the
participants themselves. Throughout the study, we will
produce newsletters for participants to update them on
our progress. The main outcomes and findings of this
feasibility study will be disseminated via publications in a
range of peer-reviewed journals. We will attend local
primary care events to raise awareness of the study, the
YP Face IT intervention and our findings among health
professionals. Additional plans to provide feedback to
the participating GP practices and charities supporting
those with conditions affecting appearance will be devel-
oped with stakeholders during the study.
DISCUSSION
Limitations and strengths of the YP face IT feasibility
study
The study aims to establish whether it is acceptable and
feasible to conduct an RCT to evaluate YP Face IT as an
adjunct to TAU in a primary care setting. The data col-
lected during the study will be essential to inform the
design and delivery of a large-scale definitive trial. The
need to improve support for young people distressed by
appearance-altering conditions has been recognised by
parents and NHS health professionals for some time.15
Strengths of this study include the development of an
innovative, easily accessible online intervention with the
potential to improve outcomes for young people strug-
gling with appearance-related concerns, a population
who currently have limited access to evidence-based psy-
chosocial support. However, there are some limitations
to the study. First, allocation to TAU may be confounded
if young people and their parents are disappointed and
try to seek help elsewhere, however, this will be depend-
ent on available alternative resources, which are cur-
rently limited. To account for this, we will record TAU
received by participants via the health economic data
collection tools, note reviews and participant interviews.
Second, we require participants to have access to the
internet and this might restrict access to those with
lower socioeconomic status and is something to consider
for the future RCT. Finally, the self-report measures
selected might not be sensitive to all aspects of improve-
ments and may result in reporting bias as young people
will not be blinded to their allocation. Despite these lim-
itations, if an RCT is considered feasible, in the future,
we hope that YP Face IT will be made widely available
throughout the NHS to support those young people
with visible differences who are struggling with
appearance-related distress.
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